Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of bevacizumab/temsirolimus
is effective in patients with advanced renal carcinoma progressing after anti-VEGF treatment